Tranexamic acid 250 mg, 500 mg, 750 mg and 1000 mg tablets, is indicated for the short-term use for hemorrhage or risk of hemorrhage caused by fibrinolysis, drug-induced fibrinolysis, general fibrinolysis (in prostate cancer and pancreas cancer) and local fibrinolysis.
Dossier available soon
Tranexamic Acid – 250 mg, 500 mg, 750 mg & 1000 mg tablets